Breast Screening and Survival: Results from the Swedish Two-County Study
Author Information
Author(s): S.W. Duffy, L. Tabar, G. Fagerberg, A. Gad, O. Gr6ntoft, M.C. South, N.E. Day
Primary Institution: MRC Biostatistics Unit
Hypothesis
How do prognostic factors like tumor size, nodal status, and malignancy grade relate to breast cancer screening and survival?
Conclusion
The study found that screening significantly improves survival rates by detecting cancers at an earlier stage.
Supporting Evidence
- Screening reduces the rates of larger tumors and metastases.
- Malignancy grade worsens as tumor size increases.
- Screen-detected cancers have better survival rates compared to those detected in interval screenings or control groups.
Takeaway
This study shows that getting regular breast cancer screenings can help doctors find tumors earlier, which can lead to better survival rates.
Methodology
Data from the Swedish two-county trial of mammographic screening for breast cancer was analyzed, focusing on women aged 40-69.
Potential Biases
Differences in malignancy grade assessment between pathologists could introduce bias.
Limitations
The study did not include tumors in situ and relied on histological examination, which may have subjective biases.
Participant Demographics
Women aged 40-69, with good compliance to screening.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website